182 related articles for article (PubMed ID: 17460439)
1. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.
Taniguchi M; Tsurikisawa N; Higashi N; Saito H; Mita H; Mori A; Sakakibara H; Akiyama K
Allergol Int; 2007 Jun; 56(2):97-103. PubMed ID: 17460439
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
3. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature.
Agard C; Rendu E; Leguern V; Ponge T; Masseau A; Barrier JH; Trochu JN; Hamidou MA; Guillevin L
Semin Arthritis Rheum; 2007 Jun; 36(6):386-91. PubMed ID: 17303217
[TBL] [Abstract][Full Text] [Related]
4. [Churg-Strauss syndrome].
Lhote F
Presse Med; 2007 May; 36(5 Pt 2):875-89. PubMed ID: 17408916
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.
Tsurikisawa N; Taniguchi M; Saito H; Himeno H; Ishibashi A; Suzuki S; Akiyama K
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):80-7. PubMed ID: 14756469
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations and treatment of Churg-Strauss syndrome.
Baldini C; Talarico R; Della Rossa A; Bombardieri S
Rheum Dis Clin North Am; 2010 Aug; 36(3):527-43. PubMed ID: 20688248
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy.
Nakamura M; Yabe I; Yaguchi H; Kishimoto R; Mito Y; Fujiki N; Houzen H; Tsuji-Akimoto S; Niino M; Sasaki H
Clin Neurol Neurosurg; 2009 Oct; 111(8):683-7. PubMed ID: 19647930
[TBL] [Abstract][Full Text] [Related]
8. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
9. [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
Hellmich B; Metzler C; Gross WL
Dtsch Med Wochenschr; 2006 Oct; 131(41):2270-4. PubMed ID: 17036268
[No Abstract] [Full Text] [Related]
10. Successful treatment of a patient with severe Churg-Strauss syndrome by a combination of pulse corticosteroids, pulse cyclophosphamide, and high-dose intravenous immunoglobulin.
Takigawa N; Kawata N; Shibayama T; Tada A; Kimura G; Munemasa M; Soda R; Takahashi K
J Asthma; 2005 Oct; 42(8):639-41. PubMed ID: 16266953
[TBL] [Abstract][Full Text] [Related]
11. Successful multidrug treatment of a pediatric patient with severe Churg-Strauss syndrome refractory to prednisolone.
Watanabe S; Aizawa-Yashiro T; Tsuruga K; Takahashi T; Ito E; Tanaka H
Tohoku J Exp Med; 2011 Oct; 225(2):117-21. PubMed ID: 21914976
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
[TBL] [Abstract][Full Text] [Related]
13. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
Guillevin L; Lhote F
Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
[TBL] [Abstract][Full Text] [Related]
14. [The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].
Szczeklik W; Sokołowska BM; Mastalerz L; Górka J; Pacułt K; Soja J; Musiał J
Przegl Lek; 2010; 67(7):439-42. PubMed ID: 21387750
[TBL] [Abstract][Full Text] [Related]
15. Churg-Strauss syndrome and persistent heart failure: active disease or damage?
Lin YC; Oliveira GH; Villa-Forte A
J Clin Rheumatol; 2013 Oct; 19(7):390-2; discussion 419. PubMed ID: 24048112
[TBL] [Abstract][Full Text] [Related]
16. Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy.
Hot A; Perard L; Coppere B; Simon M; Bouhour F; Ninet J
Clin Rheumatol; 2007 Dec; 26(12):2149-2151. PubMed ID: 17486292
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in the pharmacotherapy of Churg-Strauss syndrome.
Hellmich B; Gross WL
Expert Opin Pharmacother; 2004 Jan; 5(1):25-35. PubMed ID: 14680433
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for systemic necrotizing vasculitides.
Guillevin L; Pagnoux C
Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
[TBL] [Abstract][Full Text] [Related]
20. A severe form of Churg-Strauss syndrome complicated with acute cardiac failure and rapidly progressive peripheral neuropathy--a possible effect of intravenous immunoglobulin therapy.
Kobayashi D; Wada Y; Takata T; Koya T; Murakami S; Ozawa T; Aizawa Y; Kuroda T; Nakano M; Narita I
Intern Med; 2011; 50(8):925-9. PubMed ID: 21498944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
